Recent experience suggests that post-zygotic or mosaic mutations are a common cause of developmental disorders that can involve any organ system, although they are most easily recognized in vascular anomalies and skin. Several genes underlying rare syndromes with vascular anomalies have been identified, but so far only two that contribute to the more common non-syndromic forms: TEK for venous malformations and PIK3CA for lymphatic malformations, the latter recent work reported by the investigators. For both of these and several syndromic forms, the mutations are found in only or primarily in affected tissue and represent mosaic mutations. We propose to identify and study the genes underlying other vascular anomalies using new genomics technologies. The genetics community has rapidly moved to whole exome (WXS) or whole genome (WGS) sequencing to investigate disorders such as these, but the success rate of such studies is only ~25% when germline inheritance is expected, and much lower for patchy or asymmetric disorders that suggest mosaicism.
Our first aim i s to develop new genomic and bioinformatics methods that will more reliably detect low level mosaic mutations using massively parallel (NextGen) sequencing approaches. We will next study how the level and distribution of mosaicism affects the phenotype, focusing first on disorders with known causative genes (initially PIK3CA) that can be evaluated reliably because of vascular and/or lymphatic involvement. Finally, we will use existing and new methods to search for novel genes underlying vascular anomalies, focusing first on more common and clinically important types such as such as arteriovenous malformations, the remaining unexplained lymphatic malformations (that is, not due to PIK3CA mutations) and hemangiomas. We expect this work to significantly expand our understanding of vascular anomalies specifically and the nature of mosaicism more broadly.

Public Health Relevance

Many genetic disorders affect every cell in the body, but an emerging class of disorders is caused by 'mosaic' changes or genetic mutations that affect only a portion of cells in the body. The patchy nature of most vascular anomalies suggests that they are caused by mosaic mutations of the underlying genes. We propose to develop new methods to find these 'mosaic' genetic changes, and apply them to developmental disorders of blood and lymphatic vessels that present with asymmetric or patchy features of disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL130996-03
Application #
9417064
Study Section
Genetics of Health and Disease Study Section (GHD)
Program Officer
Tolunay, Eser
Project Start
2016-02-08
Project End
2020-01-31
Budget Start
2018-02-01
Budget End
2019-01-31
Support Year
3
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Seattle Children's Hospital
Department
Type
DUNS #
048682157
City
Seattle
State
WA
Country
United States
Zip Code
98101
Bly, Randall A; Perkins, Jonathan; Parikh, Sanjay R (2017) Can topical beta-blockers reduce the size of superficial infantile hemangiomas of the head and neck? Laryngoscope 127:4-5
Strub, Graham M; Kirsh, Andrew L; Whipple, Mark E et al. (2016) Endothelial and circulating C19MC microRNAs are biomarkers of infantile hemangioma. JCI Insight 1:e88856
Bennett, James T; Tan, Tiong Yang; Alcantara, Diana et al. (2016) Mosaic Activating Mutations in FGFR1 Cause Encephalocraniocutaneous Lipomatosis. Am J Hum Genet 98:579-587
Mirzaa, Ghayda; Timms, Andrew E; Conti, Valerio et al. (2016) PIK3CA-associated developmental disorders exhibit distinct classes of mutations with variable expression and tissue distribution. JCI Insight 1:
Luks, Valerie L; Kamitaki, Nolan; Vivero, Matthew P et al. (2015) Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CA. J Pediatr 166:1048-54.e1-5